Home ›
Investor Directory ›
Bioscience ›
Series A
Active Series A Bioscience Investors (2026)
3 investors currently writing series a checks in Bioscience. Synthesized from live platform activity · updated August 2026.
Raising capital in the Bioscience space requires finding partners who understand your specific market dynamics. The investors listed here are actively deploying capital and looking for high-growth opportunities with defensible competitive advantages. Series A investors are focused on scaling. They expect proven business models, strong unit economics, and a clear path to dominating a market segment.
Sector: Bioscience
Stage: Series A
+ Geography
+ Check size
RW
Rob Wilder
FTW Ventures is an early-stage venture fund focused on food and agricultural technology that deploys capital to support founders solving sys...
Kevin Crowley
Kevin Crowley leads Connecticut Innovations' venture debt and equity investment portfolio, focusing on closely held and venture-backed compa...
RC
Rowan Chapman
BEVC partners with entrepreneurs on their unique journeys to create, scale, and exit meaningful biotech and tech ventures. The fund invests...
Related
See which of these 3 fit your startup
Free · under a minute